| International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, P Debourdeau, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 56-70, 2013 | 589 | 2013 |
| Epidemiology and pathophysiology of cancer-associated thrombosis S Noble, J Pasi British journal of cancer 102 (S1), S2-S9, 2010 | 355 | 2010 |
| International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer P Debourdeau, D Farge, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 71-80, 2013 | 270 | 2013 |
| Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH AA Khorana, S Noble, AYY Lee, G Soff, G Meyer, C O'Connell, M Carrier Journal of Thrombosis and Haemostasis 16 (9), 1891-1894, 2018 | 199 | 2018 |
| How does the environment impact on the quality of life of advanced cancer patients? A qualitative study with implications for ward design J Rowlands, S Noble Palliative medicine 22 (6), 768-774, 2008 | 142 | 2008 |
| Management of challenging cases of patients with cancer‐associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH M Carrier, AA Khorana, JI Zwicker, S Noble, AYY Lee, ... Journal of Thrombosis and Haemostasis 11 (9), 1760-1765, 2013 | 141 | 2013 |
| Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study SIR Noble, IG Finlay Palliative Medicine 19 (3), 197-201, 2005 | 131 | 2005 |
| Research methods: Planning, conducting and presenting research AS Devlin Thomson/Wadsworth, 2006 | 128 | 2006 |
| Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial F Macbeth, S Noble, J Evans, S Ahmed, D Cohen, K Hood, D Knoyle, ... Journal of Clinical Oncology 34 (5), 488-494, 2016 | 121 | 2016 |
| Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis SIR Noble, MD Shelley, B Coles, SM Williams, A Wilcock, MJ Johnson The lancet oncology 9 (6), 577-584, 2008 | 110 | 2008 |
| Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study SIR Noble, A Nelson, C Turner, IG Finlay Bmj 332 (7541), 577-580, 2006 | 104 | 2006 |
| The assessment and impact of sarcopenia in lung cancer: a systematic literature review J Collins, S Noble, J Chester, B Coles, A Byrne BMJ open 4 (1), 2014 | 90 | 2014 |
| Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study S Seaman, A Nelson, S Noble Patient preference and adherence 8, 453, 2014 | 67 | 2014 |
| Assessing patients˘ anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology S Noble, A Matzdorff, A Maraveyas, MV Holm, G Pisa Haematologica 100 (11), 1486-1492, 2015 | 65 | 2015 |
| Long-term psychological consequences of symptomatic pulmonary embolism: a qualitative study S Noble, R Lewis, J Whithers, S Lewis, P Bennett BMJ open 4 (4), 2014 | 65 | 2014 |
| Management of terminal hemorrhage in patients with advanced cancer: a systematic literature review DG Harris, SIR Noble Journal of pain and symptom management 38 (6), 913-927, 2009 | 64 | 2009 |
| Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH BT Samuelson Bannow, A Lee, AA Khorana, JI Zwicker, S Noble, C Ay, ... Journal of Thrombosis and Haemostasis 16 (6), 1246-1249, 2018 | 62 | 2018 |
| FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragm in® a dded to standard t herapy in patients with lung c ancer GO Griffiths, S Burns, SI Noble, FR Macbeth, D Cohen, TS Maughan BMC cancer 9 (1), 1-9, 2009 | 60 | 2009 |
| Patients˘ Experiences of LIving with CANcer-associated thrombosis: the PELICAN study S Noble, H Prout, A Nelson Patient preference and adherence 9, 337, 2015 | 56 | 2015 |
| Factors influencing adherence to clinical guidelines in the management of cancer‐associated thrombosis I Mahé, J Chidiac, H Helfer, S Noble Journal of Thrombosis and Haemostasis 14 (11), 2107-2113, 2016 | 53 | 2016 |
